Fig. 4. CD27+IgD+ B cells were
increased after treatment in SLE patients. (A) Flow cytometric analysis
of the frequencies of CD27+IgD+ B
cells before and after 4 weeks of initiation of treatments. (B) SLEDAI
before and after treatment in SLE patients
(n = 12). (C) The frequencies of
CD27+IgD+ B cells in SLE patients
before and after treatment (n = 12). (*P < 0.05, **P
< 0.01).